Expanding newborn screening (NBS) to include identifying genes associated with an increased risk for neurodevelopmental disorders (NDD) would cause more harm than good, according to an article published in Pediatrics. While some experts believe early identification of NDDs in the newborn period would provide an equitable way to flag and treat disabilities early, the authors